Dashboard
Manage Tickers

RXRX


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

decoding-6-analyst-evaluations-for-recursion-pharmaceuticals
Decoding 6 Analyst Evaluations For Recursi...
09/04/2024 15:00:37

needham-maintains-buy-on-recursion-pharmaceuticals-lowers-price-target-to-11
Needham Maintains Buy on Recursion Pharmac...
09/04/2024 10:22:54

Needham analyst Gil Blum maintains Recursion Pharmaceuticals (NASDAQ:RXRX) with a Buy and lowers the price target from $16 t...

crude-oil-dips-over-4-spar-group-shares-spike-higher
Crude Oil Dips Over 4%; SPAR Group Shares ...
09/03/2024 18:59:54

why-recursion-pharmaceuticals-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Recursion Pharmaceuticals Shares Are T...
09/03/2024 17:41:09

jefferies-maintains-hold-on-recursion-pharmaceuticals-lowers-price-target-to-6
Jefferies Maintains Hold on Recursion Phar...
09/03/2024 17:38:32

Jefferies analyst Dennis Ding maintains Recursion Pharmaceuticals (NASDAQ:RXRX) with a Hold and lowers the price target from...

leerink-partners-maintains-market-perform-on-recursion-pharmaceuticals-lowers-price-target-to-8
Leerink Partners Maintains Market Perform ...
09/03/2024 17:36:07

Leerink Partners analyst Mani Foroohar maintains Recursion Pharmaceuticals (NASDAQ:RXRX) with a Market Perform and lowers th...

nasdaq-dips-over-2-us-construction-spending-falls-in-july
Nasdaq Dips Over 2%; US Construction Spend...
09/03/2024 16:00:51

recursion-pharmaceuticals-stock-is-sliding-tuesday-whats-going-on
Recursion Pharmaceuticals Stock Is Sliding...
09/03/2024 13:28:01

Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares are trading lower. The company on Tuesday announced Phase 2 data for an inve...

recursion-announces-phase-2-sycamore-trial-of-rec-994-in-symptomatic-cerebral-cavernous-malformation-mer-primary-endpoint-of-safety-and-tolerability
Recursion Announces Phase 2 SYCAMORE Trial...
09/03/2024 12:04:10

how-is-the-market-feeling-about-recursion-pharmaceuticals
How Is The Market Feeling About Recursion ...
08/23/2024 14:00:27

needham-maintains-buy-on-recursion-pharmaceuticals-lowers-price-target-to-16
Needham Maintains Buy on Recursion Pharmac...
08/09/2024 11:57:32

Needham analyst Gil Blum maintains Recursion Pharmaceuticals (NASDAQ:RXRX) with a Buy and lowers the price target from $17 t...

ai-powered-drug-discovery-firm-exscientia-to-merge-with-nvidia-partner-recursion-pharmaceuticals
AI-Powered Drug Discovery Firm Exscientia ...
08/08/2024 21:37:28

Exscientia merges with Recursion Pharmaceuticals in an all-stock deal. The new entity, named Recursion, will focus on industria...

Core News & Articles
Recursion And Exscientia Announce Definiti...
08/08/2024 11:40:39

Expect 10 Clinical Readouts In 18 Months, $200M In Milestone Payments Over 24 Months, $20B Potentially Overall, $850M Cash On H...

bank-of-new-york-mellon-posts-upbeat-earnings-joins-archer-aviation-rivian-automotive-and-other-big-stocks-moving-higher-on-friday
Bank of New York Mellon Posts Upbeat Earni...
07/12/2024 14:27:17

keybanc-maintains-overweight-on-recursion-pharmaceuticals-lowers-price-target-to-12
Keybanc Maintains Overweight on Recursion ...
07/11/2024 11:01:31

Keybanc analyst Scott Schoenhaus maintains Recursion Pharmaceuticals (NASDAQ:RXRX) with a Overweight and lowers the price ta...

cathie-woods-ark-invest-sells-tesla-shares-worth-145m-amid-rally-driven-by-q2-delivery-numbers-picks-up-palantir-shares-again-today
Cathie Wood's Ark Invest Sells Tesla Share...
07/03/2024 02:26:04

cathie-wood-led-ark-invest-scoops-up-516m-worth-of-palantir-shares-amid-raging-ai-fervor
Cathie Wood-Led Ark Invest Scoops Up $5.16...
07/02/2024 02:19:31

why-recursion-pharmaceuticals-stock-is-tumbling-thursday
Why Recursion Pharmaceuticals Stock Is Tum...
06/27/2024 13:19:50

Recursion announced that it intends to offer and sell 30,769,230 shares of its common stock for $6.50 per share in an underwri...

Core News & Articles
Market-Moving News for June 27th
06/27/2024 12:37:40

CASI: 92% | CASI Pharmaceuticals Announced Plan To Submit CID-103 IND Application; Also Announces Receipt Of A Non-binding Prop...

levi-strauss-posts-mixed-results-joins-walgreens-aerovironment-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Levi Strauss Posts Mixed Results, Joins Wa...
06/27/2024 12:33:51

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION